Jennifer Jarrett
Director, President and CEO at Damora Therapeutics; Chief Operating Officer at Arcus Biosciences; Director at Syndax Pharmaceuticals. Based in Waltham, Massachusetts.
- Rank
- 5979th of 14,644
- Companies held
- 3
- Largest holding
- DMRA, 75.4% of total
- Latest SEC filing
- Sep 25, 2026
What the $16.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Damora Therapeutics DMRA Ordinary Shares | Directly | 512,500 | $24.30 | $12.5M | 75.4% | Form 4, Sep 25, 2026 |
| Arcus Biosciences RCUS Common Stock | Directly | 224,024 | $15.78 | $3.5M | 21.4% | Form 4, Jan 23, 2026 |
| Syndax Pharmaceuticals SNDX Common Stock | Directly Reported jointly by 2 insiders; split evenly | 57,000 | $9.13 | $520K | 3.2% | Form 4, Feb 4, 2026 |
Share counts are the amounts Jennifer Jarrett reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5976 | John Lycouris Head of Energy Transition, Dorian LPG. Stamford, CT | $16.5M |
| 5977 | Rudolf A. Bless Chief Accounting Officer, Bank of America. Charlotte, NC | $16.5M |
| 5978 | Richard V. McPhail EVP & CFO, The Home Depot. Atlanta, GA | $16.5M |
| 5979 | Jennifer Jarrett Director, President and CEO, Damora Therapeutics. Waltham, MA | $16.5M |
| 5980 | Blake Borgeson Director, Recursion Pharmaceuticals. Salt Lake City, UT | $16.5M |
| 5981 | Jason Klurfeld General Counsel, Evercore. New York, NY | $16.5M |
| 5982 | Glenn A. Eisenberg Executive Vice President, Labcorp Holdings. Northridge, CA | $16.5M |
Other Damora Therapeutics insiders
All DMRA insiders- L. Becker Hewes$6.4MChief Medical Officer. #12132 overall
Questions
How much stock does Jennifer Jarrett own?
Jennifer Jarrett holds $16,509,259 in listed stock based on SEC filings and current prices, mostly Damora Therapeutics (DMRA). That ranks 5979th on the Stock Rich List.
Is this Jennifer Jarrett's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Jennifer Jarrett last buy or sell stock?
The most recent open-market trade on file is a purchase of 12,500 DMRA shares on Sep 25, 2026 at $20.23.